Teresa Rice, MD
Transplant Surgery · Charleston, SCNPI 1043576101
Payments from drug & device makers
What this record shows
This record is dominated by education: $9,756 of the $13,983 with a category attached, or 69.8%. Intuitive Surgical accounts for 92.4% of it on its own, with 8 other manufacturers making up the rest.
Across 43 payments — averaging $325.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- Davol Inc.$258
- Sanofi-aventis U.S. LLC$202
- Organox Ltd$185
- Integra Lifesciences Corporation$175
- Veloxis Pharmaceuticals, Inc.$120
- plus $119 from 3 others
What the payments were for
- Speaking & faculty fees$5004%
- Travel & lodging$1,51411%
- Food & beverage$2,17916%
- Education$9,75670%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 30 | $12,924 |
| Davol Inc. | 2 | $258 |
| Sanofi-aventis U.S. LLC | 2 | $202 |
| Organox Ltd | 4 | $185 |
| Integra Lifesciences Corporation | 1 | $175 |
| Veloxis Pharmaceuticals, Inc. | 1 | $120 |
| United Therapeutics Corporation | 1 | $82 |
| Medtronic | 1 | $22 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,529
- DAVINCI XI$4,000
- Phasix Mesh$258
- SURGIMEND$175
- Envarsus$120
- THYMOGLOBULIN$116
How this compares
Too few transplant surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Envarsus XrTacrolimus | 11 | $17,267 |
| Valganciclovir Hcl | 71 | $17,018 |
| Mycophenolate Mofetil | 19 | $1,725 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 144 | $1,250 |
| Famotidine | 67 | $905 |
| Prednisone | 43 | $284 |
| Carvedilol | 38 | $229 |
| Pantoprazole Sodium | 23 | $224 |
| Gabapentin | 43 | $119 |
| Atorvastatin Calcium | 21 | $109 |
| Acyclovir | 12 | $90 |
| Tamsulosin Hcl | 13 | $69 |
| Amlodipine Besylate | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Charleston
- Santosh NagarajuCharleston$8K
- Christof KaltenmeierCharleston$313
- Siddharth JainCharleston$202
- Pradi RajagopalanCharleston$50
- Ivaylo MitsievCharleston$26
- Derek DubayGreenville$9K
- Altan AlimGreenville$944
- Todd MerchenGreenville$562
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.